Le Lézard
Classified in: Health
Subjects: NPT, STP, AVO

Vermont Medical Society Recognizes Medical Aid in Dying in New Policy on End-of-Life Care


MONTPELIER, Vt., Nov. 17, 2017 /PRNewswire-USNewswire/ -- Compassion & Choices praised the Vermont Medical Society for dropping its 14-year opposition to doctors writing prescriptions for terminally ill adults who request  medication to end unbearable suffering and die peacefully. The society posted a resolution recognizing medical aid in dying as a legal option that could be made within the doctor-patient relationship at its annual meeting earlier this month, 4-1/2 years after the state authorized medical aid in dying in May 2013 by passing the Patient Choice at End of Life Act (Act 39).

Rebecca Thoman, M.D., Campaign Manager for Doctors for Dignity for Compassion & Choices

"Even when physicians use all the tools at hand to care for pain and suffering, a small number of patients still suffer," says the new policy position posted on the Vermont Medical Society website at: bit.ly/2zJ2DQM. "Each of these patients is unique; each one of the patients will challenge the caregiver's skills in the extreme; and each one's care should be highly individualized and decided in private amongst the patient, physician and family. The Vermont Medical Society recognizes that medical aid in dying...is a legal option that could be made in the context of the physician-patient relationship."

Vermont is among six states that have explicitly authorized medical aid in dying (California, Colorado Montana, Oregon, Washington) along with the District of Columbia. Collectively, these seven jurisdictions represent 18 percent of the nation's population and have 40 years of combined experience with this end-of-life care option.

"We commend the Vermont Medical Society for recognizing medical aid in dying as a legitimate option for terminally ill adults to peacefully end unbearable suffering and for their commitment to ensuring that all Vermonters receive good, comprehensive palliative care," said Rebecca Thoman, M.D., Campaign Manager for Doctors for Dignity for Compassion & Choices.

The Vermont Medical Society is among nine American Medical Association state chapters that have dropped their opposition to medical aid in dying and taken a neutral stance on the practice, including eight of them in the last two years. The others are the California Medical Association in 2015, Colorado Medical Society in 2016, Maryland State Medical Society in 2016, Medical Society of the District of Columbia in 2016, Maine Medical Association in 2017, Minnesota Medical Association in 2017, Nevada State Medical Association in 2017, and Oregon Medical Association in 1997.

Numerous national and state polls show strong support for medical aid in dying among both U.S. physicians and Americans across the ethnic, political and religious spectrum.

Compassion & Choices is the oldest nonprofit working to improve care and expand options for the end of life in the United States, with 450,000 supporters nationwide. For more information, visit: www.CompassionAndChoices.org.

Media Contact: Sean Crowley, 202.495.8520, [email protected]
Latino Media Contact: Patricia A. González-Portillo, (310) 819-0310, [email protected]

Compassion & Choices logo. (PRNewsFoto/Compassion & Choices)

SOURCE Compassion & Choices


These press releases may also interest you

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31,...

at 16:20
AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that its Board of Directors has unanimously approved plans to initiate a rights offering. The...

at 16:19
Aflac Incorporated announced today that it will release first quarter 2024 financial results after the market closes on May 1, 2024. At that time, earnings materials, including the quarterly earnings release and financial supplement, will be...

at 16:15
Medpace Holdings, Inc. ("Medpace") today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024,...

at 16:15
  Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell...



News published on and distributed by: